Please login to the form below

Not currently logged in
Email:
Password:

Hal Barron

This page shows the latest Hal Barron news and features for those working in and with pharma, biotech and healthcare.

GlaxoSmithKline agrees $2.2bn dementia mAb deal with Alector

GlaxoSmithKline agrees $2.2bn dementia mAb deal with Alector

neurodegenerative diseases,” said Hal Barron (pictured right), chief scientific officer and president R&D, GSK.

Latest news

More from news
Approximately 1 fully matching, plus 55 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Kevin Sin joins GSK Kevin Sin joins GSK

    years. Dr Hal Barron, chief scientific officer and president of research and development, GSK, said: “I am extremely excited to have Kevin join GSK. ... Sin will report to Hal Barron and will be based at the group’s San Francisco office.

  • Levinson resigns from Roche board Levinson resigns from Roche board

    He has served as CEO at Calico, Google's health research business, since its formation in September 2013 and has since been joined by former Genentech/Roche colleagues Hal Barron, David

  • Roche CMO joins Google health venture Calico Roche CMO joins Google health venture Calico

    Hal Barron among four new appointments. Dr Hal Barron has left his role as chief medical officer of Swiss pharma company Roche to join Google's recently-launched health research arm ... Dr Barron is one of four new recruits from industry and academia to

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
Employee wellbeing in creative agencies: three tips to get you started
Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
Managing unhelpful pressure in your creative agency: the human approach
Paul Hutchings, founder of fox&cat, answers the questions: what does it mean to be human in 2021? Are we putting ourselves under too much pressure?...